Admission Blood Glucose and Morbidity-Mortality in Subarachnoid Hemorrhage Patients

dc.contributor.authorCagiran, Esra
dc.contributor.authorDerbent, Abdurrahim
dc.contributor.authorCagiran, Inanc
dc.contributor.authorYuksel, Ummu Gulsum
dc.contributor.authorDalbasti, Tayfun
dc.date.accessioned2019-10-27T21:54:43Z
dc.date.available2019-10-27T21:54:43Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: The aim of the study is to investigate the relationship between admission blood glucose level and prediagnosis of diabetes mellitus (DM) and its effects on morbidity-mortality of patients with subarachnoid hemorrhage (SAH) in neurosurgical intensive care unit (ICU). Methods: After the approval of the Instutional Review Board, medical charts of 207 patients hospitalized in neurosurgical ICU from 1st January 2008 to 31st December 2009 with the diagnosis of SAH were reviewed retrospectively. Blood glucose level, history of DM and comorbidities during admission and morbidity-mortality (Group 1 is discharged, Group 2 exitus and Group 3 admitted to 3rd degree ICU), presence of infection and treatment type in neurosurgical ICU are investigated by reviewing the patient charts. Results: No significant relationship was found between an evident history of DM and morbidity-mortality (p>0.05). Regarding the relationship between admission blood glucose level and morbidity-mortality, the difference between Group 1 and Group 2 was significant (p<0.05). A statistically significant relationship was found between a history of DM and infection (p<0.05). The same significancy appeared as an elevated admission blood glucose level and in infection (p<0.05). The rate of co-morbidities was higher in subjects who died. Conclusions: In this study, we assumed that even without the presence of prediagnosis of DM elevated admission blood glucose level and significantly increased the incidence of morbidity-mortality in SAH patients in the neurosurgical ICU. In addition, presence of prediagnosed DM and high level of blood glucose level during admission, increase infection rates during neurosurgical ICU treatment period.en_US
dc.identifier.endpage177en_US
dc.identifier.issn1302-1664
dc.identifier.issn1302-1664en_US
dc.identifier.issue1en_US
dc.identifier.startpage168en_US
dc.identifier.urihttps://hdl.handle.net/11454/48124
dc.identifier.volume30en_US
dc.identifier.wosWOS:000318549800018en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherJournal Neurological Sciencesen_US
dc.relation.ispartofJournal of Neurological Sciences-Turkishen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSubarachnoid Hemorrhageen_US
dc.subjectAdmission blood glucoseen_US
dc.subjectMorbidity- mortalityen_US
dc.titleAdmission Blood Glucose and Morbidity-Mortality in Subarachnoid Hemorrhage Patientsen_US
dc.typeArticleen_US

Dosyalar